Wen Cong Huang
Direktor/Vorstandsmitglied bei Konfoong Biotech International Co., Ltd.
Aktive Positionen von Wen Cong Huang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Konfoong Biotech International Co., Ltd.
Konfoong Biotech International Co., Ltd. Medical SpecialtiesHealth Technology Konfoong Biotech International Co., Ltd. is a high-tech bio-information technology enterprise based in China. The Chinese company has built numerous pathology teleconsultation platforms, including several provincial centers nationwide, and its digital pathology products have been implemented in almost 1,000 hospitals across the country. Konfoong Biotech has also been actively incorporating artificial intelligence technology to promote product innovation and has launched over 10 artificial intelligence-aided pathology diagnosis projects, such as cervical fluid-based cytology, liver pathology, kidney pathology, and breast pathology, to develop intelligent pathology-aided diagnosis systems. The company was founded in 2011 by Bing Xian Liu, who has been the CEO since then. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Wen Cong Huang
Statistik
International
China | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Konfoong Biotech International Co., Ltd.
Konfoong Biotech International Co., Ltd. Medical SpecialtiesHealth Technology Konfoong Biotech International Co., Ltd. is a high-tech bio-information technology enterprise based in China. The Chinese company has built numerous pathology teleconsultation platforms, including several provincial centers nationwide, and its digital pathology products have been implemented in almost 1,000 hospitals across the country. Konfoong Biotech has also been actively incorporating artificial intelligence technology to promote product innovation and has launched over 10 artificial intelligence-aided pathology diagnosis projects, such as cervical fluid-based cytology, liver pathology, kidney pathology, and breast pathology, to develop intelligent pathology-aided diagnosis systems. The company was founded in 2011 by Bing Xian Liu, who has been the CEO since then. | Health Technology |
- Börse
- Insiders
- Wen Cong Huang
- Erfahrung